Walking Fish Therapeutics
Latest round
- Series A
Last raised
- Feb 2022
Total raised
- $41M
Investors
- 6
About Walking Fish Therapeutics
Walking Fish Therapeutics, Inc.Founded in 2019 and headquartered in South San Francisco, US, Walking Fish Therapeutics, Inc. specializes in B cell therapeutics. Founder Thomas Brennan has a history of entrepreneurship in the biotechnology sector, contributing to the company’s strategic direction.Walking Fish Therapeutics develops a range of B cell therapeutics, specifically targeting oncology, rare diseases, regenerative medicine, and autoimmune conditions.
Who invested in Walking Fish Therapeutics
6 investors across 2 rounds
See all investors in Walking Fish Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Walking Fish Therapeutics
Who invested in Walking Fish Therapeutics?
Walking Fish Therapeutics has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Walking Fish Therapeutics raised?
Walking Fish Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Walking Fish Therapeutics last raise money?
Walking Fish Therapeutics's most recent round on record is a Series A, in Feb 2022.
What does Walking Fish Therapeutics do?
Walking Fish Therapeutics, Inc.
Where is Walking Fish Therapeutics headquartered?
Walking Fish Therapeutics is headquartered in South San Francisco, US.
Which VCs invest in companies like Walking Fish Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Walking Fish Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Walking Fish Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.